Plain-English translation of NCT06773897 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Rutgers University are conducting an online study to identify genetic factors that influence breast cancer risk. Scientists know that genes like BRCA1 and BRCA2 account for only about 25% of inherited breast cancer risk, so this study aims to discover other genetic clues. By studying DNA from thousands of people — both those who have had breast cancer and those who haven't — researchers hope to develop better treatments and prevention strategies.
Most genetic causes of breast cancer remain unknown, which limits doctors' ability to predict who is at highest risk and develop targeted treatments. This study will fill that gap by identifying new genetic factors, helping pave the way for improved therapies and prevention options.
You likely qualify if…
You likely don't qualify if…
You will complete an online survey about your health history (taking about 20 minutes), then mail back a saliva sample using a pre-paid kit sent to your home. Researchers may also invite you to share your electronic health records, but this is optional. Throughout the study, you'll receive short monthly newsletters to stay informed about the research progress.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States
Sponsor
Rutgers, The State University of New Jersey
Collaborators
Regeneron Pharmaceuticals
Enrollment target
~25,000 participants
Started
April 2024
Primary completion
April 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tara Matise, Ph.D.
Rutgers, The State University of New Jersey
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.